Advanced APMs and the Emerging Role of Immuno-Oncology Agents: Balancing Innovation and ValueFebruary 16th 2017
The shift to value-based care, concurrent with innovations in immune-based care, will create challenges in oncology. What should be the physician and manufacturer responsibility during these changing times?
Partnering With a Payer to Develop a Value-Based Medical Home Pilot: A West Coast Practice's ExperienceMay 10th 2012
The Wilshire Oncology Medical Group developed a medical oncology home pilot to offer a transparent, high-quality, high-value cancer program in partnership with its largest California health plan, Anthem Blue Cross WellPoint.